1. Home
  2. KPRX vs UUU Comparison

KPRX vs UUU Comparison

Compare KPRX & UUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPRX
  • UUU
  • Stock Information
  • Founded
  • KPRX 1998
  • UUU 1969
  • Country
  • KPRX United States
  • UUU United States
  • Employees
  • KPRX N/A
  • UUU N/A
  • Industry
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • UUU Electronic Components
  • Sector
  • KPRX Health Care
  • UUU Technology
  • Exchange
  • KPRX Nasdaq
  • UUU Nasdaq
  • Market Cap
  • KPRX 9.2M
  • UUU 9.8M
  • IPO Year
  • KPRX N/A
  • UUU N/A
  • Fundamental
  • Price
  • KPRX $2.75
  • UUU $4.53
  • Analyst Decision
  • KPRX Strong Buy
  • UUU
  • Analyst Count
  • KPRX 1
  • UUU 0
  • Target Price
  • KPRX $10.00
  • UUU N/A
  • AVG Volume (30 Days)
  • KPRX 35.6K
  • UUU 260.1K
  • Earning Date
  • KPRX 11-07-2025
  • UUU 11-18-2025
  • Dividend Yield
  • KPRX N/A
  • UUU 22.22%
  • EPS Growth
  • KPRX N/A
  • UUU N/A
  • EPS
  • KPRX N/A
  • UUU 1.19
  • Revenue
  • KPRX N/A
  • UUU $22,789,285.00
  • Revenue This Year
  • KPRX N/A
  • UUU N/A
  • Revenue Next Year
  • KPRX N/A
  • UUU N/A
  • P/E Ratio
  • KPRX N/A
  • UUU $4.19
  • Revenue Growth
  • KPRX N/A
  • UUU 30.84
  • 52 Week Low
  • KPRX $2.25
  • UUU $1.15
  • 52 Week High
  • KPRX $4.18
  • UUU $8.27
  • Technical
  • Relative Strength Index (RSI)
  • KPRX 55.26
  • UUU 46.19
  • Support Level
  • KPRX $2.67
  • UUU $4.00
  • Resistance Level
  • KPRX $2.89
  • UUU $5.02
  • Average True Range (ATR)
  • KPRX 0.11
  • UUU 0.73
  • MACD
  • KPRX 0.02
  • UUU -0.26
  • Stochastic Oscillator
  • KPRX 70.26
  • UUU 16.18

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About UUU Universal Security Instruments Inc.

Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.

Share on Social Networks: